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In recent years, the NationallTxicology Program (NTP) has selected numerous glycol ethers for testing
in routine laboratory mammals to ascertain the magnitude of their ability to injure the conceptus. From
the lists available of ongoing and projected NTP test chemicals, a series of glycol ethers was selected for
examination in vitro in the hydra assay. Also tested were additional chemicals of similar molecular
configuration and/or composition. This short-term screening test placed the 14 glycols and glycol ethers
tested into a rank order sequence according to their degree of hazard potential to developmental biology,
i.e., their ability to interfere with the developmental events characteristic of all ontogenic systems. They
were ranked according to the difference between the lowest dose orconcentration overtly toxic to adults (A)
and the lowest concentration interfering with development (D) of the artificial embryo of reaggregated
adult hydra cells and the AID ratio.
Published data from mammalian studies were available for a few of the test chemicals, and in each
instance the hydra assay was in direct agreement with the outcomes reported of the more elaborate and
standard animal tests. Ethylene glycol and ethylene glycol monomethyl etherwere shown by both standard
evaluations in mammals, and by the hydra assay, to disrupt embryos only at orvery near to their respective
adult toxic doses, whereas the mono-ethyl ether perturbed development at approximately one-fifth of the
lowest dose overtly toxic to adults.
Data from the hydra prescreen predict that, when tested by the NTP or other sponsor in the standard
protocols employing mammals, the majority ofthe additional glycols and glycol ethers tested in hydra will
be found capable ofdisrupting embryonic development only at, or very near to, exposure levels also overtly
toxic to adults treated by the same route of administration. That is, they actually are not high priority
items for additional testing provided human exposures are not anticipated at or near their respective adult
toxic dose levels.
No obvious structure activity relationship between these molecules and their developmental toxicity was
found in the group assayed in hydra.
The glycol ethers are a class of substances widely
used in contemporary society. For this and other cogent
reasons they are the subject of considerable interest
regardingtheir possible toxicity. Most ofthe more usual
members have been at least partially tested regarding
their acute and perhaps target organ toxicity, but very
few have been examined for their ability to disrupt in
utero development. Recently, however, severalmembers
of this chemical class have been evaluated in standard
assays to determine their potential to disrupt the
conceptus and The National Toxicology Program has
tested or has cited a larger list of glycol ethers as high
priority items for developmental toxicity evaluations in
the near future (1). Such tests are-time-consuming,
require large numbers of pregnant animals, are very
expensive and require elaborate facilities and technical
expertise oflimited availability. Furthermore, and more
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relevant to this report, is the fact that the means
presently available to select candidates for such defini-
tive studies are imprecise and, of necessity, represent
educated guesses at best because until now we have
lacked a nonambiguous and biologically relevant
screening system to quantifiably prioritize previously
untested substances regarding their hazard potential
for the conceptus.
Duringthe past severalyears ourlaboratory has been
developing (2,3) and then documenting (4,5) the ability
and reliability of an in vitro developmental toxicity
screening system to predict and recapitulate experi-
mental findings of rigorously executed developmental
toxicity evaluations made by state-of-the-art protocols
in the more standard laboratory animals. The hydra
assaydemonstrated aremarkable ability torecapitulate
the dataofcomplex studiesmade inpregnantmammals,
and itbegan to be used byprivate corporations prospec-
tively to evaluate previously untested substances. In
this vein of prospective testing to identify substancesJOHNSON, GABEL AND LARSON
uniquely hazardous to developmental biology and differ-
entiate them in a quantified or prioritized manner from
substances capable of injuring embryos only at expo-
sure levels sohigh that they were overtlytoxicto adults,
we tested several members of this chemical class. For
the present study, a number ofglycols and glycol ethers
were selected from the list ofsuch chemicals designated
for developmental toxicity testing by the NTP These
were evaluated for this parameter in the hydra assay.
Those selected were chosen, and supplemented with
additional glycols, on the basis of their molecular
structure in an attempt to reveal any possible
structure/activity relationships between one or more of
these molecule's configuration or composition and its
hazard potential fordisruptinganyofthe developmental
biologic events so characteristic ofany and all ontogenic
systems.
Materials and Methods
Adult polyps of the fresh water coelenterate Hydra
attenuata were grown in a specially prepared apparatus
where they would reproduce by asexual budding and
could be fed and cleaned of expelled detritus on a
regular schedule with aminimum oftechnical effort (4).
To begin each assay, approximately 700 to 1000 clean
adult hydra (Fig. 1A) were collected and then dissoci-
ated mechanically into their component cells which
werethenrandomlyreassociatedbybeinggentlypacked
into small pellets (Fig. 1B) through low-speed centrifu-
gation (2). Previous experimentation has established
that these randomly reaggregated cells will undergo a
full ontogenesis sequence and give rise to a new
population ofadult polyps in about 92 hr ifthey are left
undisturbed (Fig. 1C). These artificial preparations
consist of two broad classes of cells (6). The greater
number by far are fully differentiated adult cells which
quickly achieve spatial orientation and migrate to a
position consistent with their phenotype. That is,
endoderm cells ofthe original polyps become positioned
internally within the aggregate whereas the ectoderm
cells migrate to the periphery where they then form
normal intercellular membranous contacts (E. M.
Johnson, unpublished data) and begin to elaborate
extracellular matrix in the form of a new basement
membrane. The second broad class ofcells consists ofa
much smaller number of undifferentiated interstitial
cellscapabletobecominganyofthenumerous differenti-
ated cells typical of adult hydra. It is these interstitial
cells which undergo rapid and markedly localized prolif-
eration and, by means as yet undefined, are induced, in
sharply localized regions, to differentiate into tentacles
and the exquisitely elaborate nematocysts so character-
istic of these simple yet highly organized animals.
During their >90-hr period of differentiation and
organogenesis, these artificially manufactured pellets
achieve all of the developmental biologic phenomena
FIGURE 1. Micrographs showing (A) theapical end ofafullyextended
adult hydra showing the elevated hypostome and surrounding
tentacles. The entire animal is about 1 cm tall. (B) One ofabout 20
pellets (artificial "embryo") derived from repacking the dissociated
cells of 700 to 1000 adult hydra. It has begun differentiation as
evidenced by the partially smoothed external surface. This prepa-
ration is approximately 1 cm in length. (C) An artificial "embryo"
after about 92 hr of differentiation and organogenesis. Approxi-
mately 10 to 20adultswill form simultaneously from one pellet and
eventually will detach to form free-standing polyps.
136DEVELOPMENTAL TOXICITY OF GLYCOLS AND GLYCOL ETHERS
known to occur in an embryo of any species (7), and in
view of this fact, they are termed artificial 'embryos"
The testing protocol used in each evaluation was not
varied from one chemical to another and no prior
information was needed in order to test any substance.
All test chemicals were water-soluble except ethylene
glycol monophenyl ether and diethylene glycol dibutyl
ether. These were diluted using ethanol as a general
procedure in instances where insolubility is observed
with test chemical concentrations below 10 mL/L. The
protocol employed in this study was a three-step proce-
dure somewhat shortened from previous reports. It was
used twice for each chemical tested; once for "embryos"
and once for adult hydra. Step 1 employs test chemical
concentrations atwhole-logconcentrationintervalsfrom
1 x 107 through 1 x 103mL/L. Thisstepidentifiesthe
lowest whole-log concentration of the chemical capable
of disrupting development of the embryo and when
repeated with adult animals, the lowest concentration
capable ofproducing the adult endpoint sign oftoxicity.
The second step ofthe testing protocolforboth embryos
and adults againteststhe lowesttoxicwhole-log concen-
tration eliciting the toxic endpoints obtained in the first
step as well as the next lowest whole-log concentration,
i.e., the highest whole-logno-effect level. The main part
of step 2 is to test the eight 1/10 log concentrations
between these two whole-log concentrations. For
example, assume that in step 1 concentrations of 103
and 102 mL/L caused the endpoint, but a concentration
of 101 mL/L did not. In step 2, 102 mL/L, the lowest
whole-log concentration eliciting the toxic endpoint
would be rerun as would the next lowest whole-log
concentration of 101. One thereby has bracketed the
as-yet-undetermined 1/10 log dose. There are eight 1/10
log concentrations between 102 and 101, and these eight
concentrations were also run, i.e., the concentrations
tested here would be: 102 or 100, 90, 80, 70, 60, 50, 40,
30, 20 and 101 or 10 mL/L. By this protocol, this step
determines to within 1/10 log those minimal effective
concentrations (MEC) of the test substance capable of
producing adult and developmental toxicity. The final
step is a confirmation of the MEC observed in step 2.
The adult MEC (A) and the developmental MEC (D) are
calculated as a ratio. This AID ratio is considered as a
developmental toxicity hazard index whose increasing
size is directly proportional to a chemical's ability to
injure embryos in the absence of adult toxicity. The
chemicals tested are listed in Table 1.
Results
The 14 glycols and glycol ethers tested in this short
study are listed in Table 1 alone with both the adult and
the developmental MEC and their AID ratios. The
ratios varied from 1.0through 5.0with diethylene glycol
and the three acetates being the lowest. These four
chemicals proved capable of disrupting development
only at concentrations which were also toxic to the adult
animal; the minimal effective (toxic) concentration or
MEC for adult and for developmental toxicity were the
same, e.g., 30 mL/L for each in the case of diethylene
glycol. Each ofthe three acetate formstested were toxic
at rather low exposure concentrations, but each injured
the adults and "embryos" at the same concentration.
The AID ratio for ethylene glycol monoethyl ether was
5.0, and that of ethylene glycol monobutyl ether was
4.4. These were the highest in this group of chemicals.
It required 30 mL/L to produce the toxic endpoint in
adults, yet the "embryo's" development was disrupted
by only 6.0 mL in the case of the monoethyl ether, but
Table 1. Developmental toxicity hazard potential of glycols and glycol ethers.
Test chemical (CAS #)
Ethylene glycol (102-21-1)
Propylene glycol (57-55-6)
Hexylene glycol (10741-5)
Ethylene glycol monomethyl ether (109-86-4)
Ethylene glycol monoethyl ether (111-15-9)
Ethylene glycol monobutyl ether (111-76-2)
Ethylene glycol monophenyl ether (122-99-6)
Ethylene glycol monomethyl ether monoacetate (110-49-6)
Ethylene glycol monoethyl ether monoacetate (111-15-9)
Ethylene glycol diacetate (111-55-7)
A=
adult
MECa
50.0
40.0
20.0
40.0
30.0
4.0
1.0
0.7
0.6
0.2
D=
"embryo"
MECb
30.0
30.0
6.0
30.0
6.0
0.9
0.3
0.7
0.6
0.2
AID
ratioc
1.7
1.3
3.3
1.3
5.0
4.4
3.3
1.0
1.0
1.0
Diethylene glycol (111-46-6) 30.0 30.0 1.0
Diethylene glycol monomethyl ether (111-77-3) 30.0 20.0 1.5
Diethylene glycol monoethyl ether (111-90-0) 20.0 9.0 2.9
Diethylene glycol dibutyl ether (112-73-2) 0.9 0.4 2.2
aThat lowest concentration (to within 1/10 log) of the test chemical capable of producing the sign of toxicity in adult hydra.
bMEC for development of the artificial "embryo:'
cThe decimalpoints are retainedforthe sake ofarithmeticaccuracy. Such adegree ofbiologicprecision is not apossibility in anydevelopmental
toxicology safety evaluation or in this screening assay.
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the monobutyl ether achieved toxic effects at much
lower exposures. The addition ofan acetate group tothe
monoethyl ether markedly altered the AID ratio
(reduced it from 5 to 1.0). Ethylene glycol monoethyl
ether monoacetate was coeffective, i.e., both the adult
and the "embryo" were injured at the same concen-
tration. Ethylene glycolmonophenyletherand hexylene
glycol had the second highest AID ratios (3.3), and the
monophenol was also the second most toxic of the
substances tested from the point of developmental
toxicity. Only 0.3 mL/L was needed to cause an effect,
and the only chemical tested here which was toxic at a
lower exposure level was ethylene glycol diacetate.
There appeared to be no relationship between a
chemical's hazard potential to the embryo (AID ratio)
and its general toxicity, i.e., lowest exposure level
capable to producing toxicity in this system; though all
three of the acetate forms tested were coeffective and
obviously have no propensity to injure developmental
biology. Also absent is any obvious correlation between
molecular size or composition and either general tox-
icity or propensity to disrupt the developmental
sequences of the embryo. Each ofthe chemicals tested
seemed to disrupt a different phase or portion of the
"embryo" on slightly different sequences oftime or dose
response, but such is not directly relevant to the
present discussion. To be complete, it should be pointed
out that though the AID ratio proves predictive of the
ratio in mammals, the exposure levels needed to pro-
duce toxicity in hydra can be quite different from those
in mammals, where metabolism, binding or dissociation
may occur.
Discussion
Any substance administered to apregnant female will
injure the conceptus ifthe dose or exposure level is high
enough. As reluctant as some ofus maybeto acceptthis
basic fact, experimental findings cannot be ignored. To
be ofpractical utility, this concept must be placed into a
realistic perspective (8,9) consistent with knowledge
acquired bydevelopmentalbiologists overseveral centu-
ries (10). This concept must be considered in conjunc-
tion with a second basic understanding. There are four
manifestations of perturbed embryonic development:
death of the products, developmental delays (runts),
terata, and decrements ofnormally expected functional
attainment levels (11). Each ofthese is an unacceptable
developmental outcome if dose-related to any specific
agent ofeither voluntary orinvoluntary exposure. Once
these two concepts are appreciated, it becomes possible
to remove developmental toxicology from the black box
of a binary designation: teratogen vs. nonteratogen,
minor variation vs. abnormality, embryotoxic vs.
teratogenic, and one finds that quantitative risk estima-
tion based on standard safety factors is possible.
The spectrum of adult/developmental toxicity seen
here from data ofhydra and glycol ethers is identical to
the answers of the same question posed for glycols as
well as innumerable other chemicals in relation to
hazard potential for development. For instance, aspirin
administered to pregnant animals will not perturb
embryonic development until the dose level approaches
very near to that also toxic to the adult; its AID ratio is
about 2. That for benzene is less than one, indicating a
degree of maternal protection, if you will-or at least,
that developmental events of the conceptus are less
vulnerable to its action than is the adult animal. The
method by which the hydra assay achieves its relevance
as a screening system is that it establishes this relation-
ship at a fraction of the cost in time and resources as
rats and rabbits. The regulatory and safety evaluation
sceneindevelopmentaltoxicologyisconfusedbyapplica-
tion ofconcepts and terms appropriate for mutagenesis
and carcinogenesis but inappropriate and actually coun-
terproductive of embryonic safety when applied to
the myriad ofknown and unknown phenomena essential
for normal development to occur in the mammalian
conceptus (11) or the hydra "embryo" (7). One must not
confuse teratology with developmental toxicity. It is but
one of its manifestations and is no more or no less
acceptable than any ofthe other three ways in which a
developing system can exhibit injury. It is unfortunate
that we refer to the most common developmental
toxicity test (the segment II evaluation in rats and
rabbits) as the teratology test. Actually, ofcourse, it is
not designed to produce terata and would be of mark-
edly different design ifit were. It is designed to assess
the toxic effects of substances on the total develop-
mental biology ofthe conceptus and always in relation-
ship to adult toxicity and is more apt to kill embryos
than render them abnormal but alive. Thalidomide,
aspirin, table salt and vitamin A are all toxic to
embryos, but only one is ahazard to development under
normal exposure-thalidomide-and this is because it
has an AID ratio in the neighborhood of 60 (depending
on how one accounts for solubility in the published
literature on the topic, it could be calculated somewhat
higher or lower). Each of the others is no hazard to
embryos as long as the dose is not high enough to injure
the mother. Should they be used at so high an exposure
level, then surely they too would damage the embryo
(12). The hydra assay quickly sorts out the substances
worthy of closer developmental toxicity examination in
elaborate systems while clearing the reputations ofthe
great majority while also simultaneously providing a
quantified and objective rank order for each. The hydra
assay, therefore, allows us to focus attention on sub-
stances with a prediliction to disrupt development and
these become prime candidates for more definitive
evaluations in real embryos, so the no-observed effect
level canbe determined priorto cross-species extrapola-
tion after testing in mammals (13,14). The coeffective
substances merit no furthertestingin pregnant animals
as the NOEL can be extrapolated based on adult
toxicity endpoint assays.
The results ofthese hydra assays ofglycols and glycol
ethers typify results to be expected in mammals. The
great majority ofsubstances do not merit elaborate and
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time consuming studies ofdevelopmental toxicity. They
are not good candidates for elaborate and expensive
tests unless exposure expectations indicate women will
be exposed to near adult toxic levels. All hydra does is
quicklyidentifythismajoritywhilerankingtheminority
according to their degree of hazard to developmental
phenomena. It is excellent for quantitative hazard
detection because it predicts the AID ratio. It is
irrelevant to quantitative risk estimation, because the
doses in hydra are often quite different from those
needed to produce mammalian toxicity. None of the
glycols orglycol ethers tested has amarked predilection
for the embryo. Most disrupt development only at or
near adult toxic exposure levels, but a few have some
modest ability to perturb developmental biology at a
fraction of the concentration toxic to adults.
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